Dibucaine
Dibucaine (Cinchocaine) is a sodium channel inhibitor. Dibucaine is a potent SChE inhibitor[1][2].
Product Specifications
CAS Number
[85-79-0]
Product Name Alternative
Cinchocaine
UNSPSC
12352005
Hazard Statement
H315-H319-H320
Target
Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Dibucaine.html
Purity
99.81
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(OCCCC)=NC2=CC=CC=C12)NCCN(CC)CC
Molecular Formula
C20H29N3O2
Molecular Weight
343.46
Precautions
P264-P280-P302+P352-P305+P351+P338-P362
References & Citations
[1]Souto-Padron, T., A.P. Lima, and O. Ribeiro Rde, Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi. Parasitol Res, 2006. 99 (4) : p. 317-20.|[2]Elamin, B., Dibucaine inhibition of serum cholinesterase. J Biochem Mol Biol, 2003. 36 (2) : p. 149-53.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TP310385 20 µg
Melatonin Receptor 1A (MTNR1A) (NM_005958) Human Recombinant Protein
Ask
View Details sc-493565 5 mg
3- (4-fluorophenyl) -2-methyl-8-nitro-2,3,5,6-tetrahydro-4H-2,6-methano-1,3,5-benzoxadiazocin-4-one
Ask
View Details 